Clinical Trial Update: Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluated the safety and preliminary efficacy of ProQuad in children 6-24 months being evaluated for solid organ transplant; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Disease
• Liver Failure

Drugs mentioned

• ProQuad (Measles, Mumps, Rubella and Varicella live attenuated vaccine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: RENAL INSUFFICIENCY, CHRONIC, LIVER FAILURE, ACUTE | EARLY_Phase 1 | Status: COMPLETED